7-Hydroxystaurosporine (UCN-01) preferentially sensitizes cells with a disrupted TP53 to gamma radiation in lung cancer cell lines

HH Xiao, Y Makeyev, J Butler, B Vikram… - Radiation …, 2002 - meridian.allenpress.com
Abstract Xiao, HH, Makeyev, Y., Butler, J., Vikram, B. and Franklin, WA 7-
Hydroxystaurosporine (UCN-01) Preferentially Sensitizes Cells with a Disrupted TP53 to …

Abrogation of radiation-induced G2 arrest and radiosensitization by 7-hydroxystaurosporine (UCN-01) in human nasopharyngeal carcinoma cell line

ZG Hui, YX Li, WZ Yang, JX Wu… - Ai zheng= Aizheng …, 2003 - europepmc.org
BACKGROUND & OBJECTIVE: To enhance the radiosensitivity of cancer cell is one of the
most important way to improve the effect of radiotherapy. This study was designed to …

Enhancement of radiation cytotoxicity by UCN-01 in non-small cell lung carcinoma cells

PC Mack, AA Jones, MH Gustafsson… - Radiation …, 2004 - meridian.allenpress.com
Abstract Mack, PC, Jones, AA, Gustafsson, MH, Gandara, DR, Gumerlock, PH and Goldberg,
Z. Enhancement of Radiation Cytotoxicity by UCN-01 in Non-small Cell Lung Carcinoma …

Mechanisms of radiation enhancement by the CHK1 inhibitor PF-477736

C Cullinane, J Raleigh, K Anderes, G McArthur - Cancer Research, 2007 - AACR
Abstract 5386 CHK1 kinase is a key regulator of the S and G2 cell cycle checkpoints that are
activated in response to DNA damage. Cell cycle arrest upon DNA damage checkpoint …

Targeted radiosensitization by the Chk1 inhibitor SAR-020106

GR Borst, M McLaughlin, JN Kyula, S Neijenhuis… - International Journal of …, 2013 - Elsevier
PURPOSE: To explore the activity of a potent Chk1 inhibitor (SAR-020106) in combination
with radiation. METHODS AND MATERIALS: Colony and mechanistic in vitro assays and a …

Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects of p53 and cell cycle checkpoints

Y Tao, C Leteur, C Yang, P Zhang, M Castedo… - Cell Cycle, 2009 - Taylor & Francis
Checkpoint kinase-1 (CHK1) is a key regulator of the DNA damage-elicited G2-M
checkpoints. The aim of the present study was to investigate the effects of a selective CHK1 …

[HTML][HTML] MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells

KA Bridges, X Chen, H Liu, C Rock, TA Buchholz… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Radiotherapy is commonly used to treat a variety of solid tumors but improvements in the
therapeutic ratio are sorely needed. The aim of this study was to assess the Chk1 kinase …

In vitro and In vivo Radiation Sensitization of Human Tumor Cells by a Novel Checkpoint Kinase Inhibitor, AZD7762

JB Mitchell, R Choudhuri, K Fabre, AL Sowers… - Clinical cancer …, 2010 - AACR
Purpose: Inhibition of checkpoint kinase 1 has been shown to enhance the cytotoxicity of
DNA-damaging targeted chemotherapy through cell cycle checkpoint abrogation and …

p53‐dependent G1 arrest in 1st or 2nd cell cycle may protect human cancer cells from cell death after treatment with ionizing radiation and Chk1 inhibitors

L Petersen, G Hasvold, J Lukas, J Bartek… - Cell …, 2010 - Wiley Online Library
Objectives: This study was performed to explore the strategy of combining Chk1 inhibitors
with ionizing radiation (IR) to selectively target p53‐deficient cancer cells. Materials and …

p53-Dependent Chk1 Phosphorylation is Required for Maintenance of Prolonged G2 Arrest

XQ Wang, EJ Stanbridge, X Lao, Q Cai… - Radiation …, 2007 - meridian.allenpress.com
Abstract Wang, XQ, Stanbridge, EJ, Lao, XY, Cai, Q., Fan, ST and Redpath, JL p53-
Dependent Chk1 Phosphorylation is Required for Maintenance of Prolonged G2 Arrest …